Pleiotropic Effects of Mitiglinide in Type 2 Diabetes Mellitus

Author： Konya H   Miuchi M   Konishi K   Nagai E   Ueyama T   Kusunoki Y   Kimura Y   Nakamura Y   Ishikawa T   Inokuchi C   Katsuno T   Hamaguchi T   Miyagawa J   Namba M  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.37, Iss.6, 2009-11, pp. : 1904-1912

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitiglinide for type 2 diabetes treatment

By Phillippe Haley M   Wargo Kurt A  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 15, 2013-10 ,pp. : 2133-2144

Informa Healthcare

Access to resources Recommend Favorite

Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus

By Ono Yuri   Kameda Hiraku   Cho Kyu Yong  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 361-370

Informa Healthcare

Access to resources Recommend Favorite

Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus

By Inoue Masahiro  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2257-2268

Informa Healthcare

Access to resources Recommend Favorite

Multicentre, Double-blind, Randomized Study of Mitiglinide Compared with Nateglinide in Type 2 Diabetes Mellitus Patients in China

By Gao X    

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 812-821

Field House Publishing

Access to resources Recommend Favorite

Cilostazol: beneficial lipid effects in IGT/type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1293, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite